ID   ITPR3_RAT               Reviewed;        2670 AA.
AC   Q63269;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 191.
DE   RecName: Full=Inositol 1,4,5-trisphosphate-gated calcium channel ITPR3 {ECO:0000305};
DE   AltName: Full=IP3 receptor isoform 3;
DE            Short=IP3R-3 {ECO:0000303|PubMed:8388391};
DE            Short=InsP3R3;
DE   AltName: Full=Inositol 1,4,5-trisphosphate receptor type 3;
DE   AltName: Full=Type 3 inositol 1,4,5-trisphosphate receptor;
DE            Short=Type 3 InsP3 receptor;
GN   Name=Itpr3 {ECO:0000312|RGD:2934};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=8388391; DOI=10.1016/s0021-9258(18)82132-9;
RA   Blondel O., Takeda J., Janssen H., Seino S., Bell G.I.;
RT   "Sequence and functional characterization of a third inositol trisphosphate
RT   receptor subtype, IP3R-3, expressed in pancreatic islets, kidney,
RT   gastrointestinal tract, and other tissues.";
RL   J. Biol. Chem. 268:11356-11363(1993).
RN   [2]
RP   INTERACTION WITH TRPC4.
RX   PubMed=11163362; DOI=10.1016/s0014-5793(00)02362-0;
RA   Mery L., Magnino F., Schmidt K., Krause K.-H., Dufour J.-F.;
RT   "Alternative splice variants of hTrp4 differentially interact with the C-
RT   terminal portion of the inositol 1,4,5-trisphosphate receptors.";
RL   FEBS Lett. 487:377-383(2001).
RN   [3]
RP   INTERACTION WITH SIGMAR1.
RX   PubMed=11149946; DOI=10.1073/pnas.98.2.491;
RA   Hayashi T., Su T.-P.;
RT   "Regulating ankyrin dynamics: roles of sigma-1 receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:491-496(2001).
RN   [4]
RP   INTERACTION WITH CABP1.
RX   PubMed=12032348; DOI=10.1073/pnas.102006299;
RA   Yang J., McBride S., Mak D.-O.D., Vardi N., Palczewski K., Haeseleer F.,
RA   Foskett J.K.;
RT   "Identification of a family of calcium sensors as protein ligands of
RT   inositol trisphosphate receptor Ca(2+) release channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7711-7716(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-934 AND SER-2669, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   INTERACTION WITH BOK.
RX   PubMed=23884412; DOI=10.1074/jbc.m113.496570;
RA   Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J.;
RT   "The Bcl-2 protein family member Bok binds to the coupling domain of
RT   inositol 1,4,5-trisphosphate receptors and protects them from proteolytic
RT   cleavage.";
RL   J. Biol. Chem. 288:25340-25349(2013).
CC   -!- FUNCTION: Inositol 1,4,5-trisphosphate-gated calcium channel that, upon
CC       1D-myo-inositol 1,4,5-trisphosphate binding, transports calcium from
CC       the endoplasmic reticulum lumen to cytoplasm, thus releasing the
CC       intracellular calcium and therefore participates in cellular calcium
CC       ion homeostasis (By similarity). 11D-myo-inositol 1,4,5-trisphosphate
CC       binds to the ligand-free channel without altering its global
CC       conformation, yielding the low-energy resting state, then progresses
CC       through resting-to preactivated transitions to the higher energy
CC       preactivated state, which increases affinity for calcium, promoting
CC       binding of the low basal cytosolic calcium at the juxtamembrane domain
CC       (JD) site, favoring the transition through the ensemble of high-energy
CC       intermediate states along the trajectory to the fully-open activated
CC       state (By similarity). Upon opening, releases calcium in the cytosol
CC       where it can bind to the low-affinity cytoplasmic domain (CD) site and
CC       stabilizes the inhibited state to terminate calcium release (By
CC       similarity). {ECO:0000250|UniProtKB:Q14573}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000250|UniProtKB:Q14573};
CC   -!- ACTIVITY REGULATION: Inositol 1,4,5-trisphosphate-gated calcium channel
CC       is regulated by cytosolic calcium in a biphasic manner. At low
CC       concentrations, cytosolic calcium binds at a high-affinity
CC       juxtamembrane domain (JD) calcium binding site, allowing ITPR3 to
CC       activate by escaping a low-energy resting state through an ensemble of
CC       preactivated states. At high cytosolic calcium concentrations, ITPR3
CC       preferentially enters an inhibited state stabilized by calcium binding
CC       at a second, low-affinity cytoplasmic domain (CD) calcium binding site.
CC       {ECO:0000250|UniProtKB:Q14573}.
CC   -!- SUBUNIT: Homotetramer (By similarity). Homodimer (By similarity).
CC       Interacts with TRPC1 and TRPC3 (By similarity). Interacts with TRPC4
CC       (PubMed:11163362). Interacts with TRPV4 (By similarity). Interacts with
CC       SIGMAR1 (PubMed:11149946). Interacts with AKT1 and PML. Interacts with
CC       IRAG2 (via coiled-coil domain) (By similarity). Interacts with CABP1
CC       (PubMed:12032348). Interacts with TMBIM4/LFG4 (By similarity).
CC       Interacts with CEMIP (By similarity). Interacts with TESPA1 (By
CC       similarity). Interacts with TMEM203 (By similarity). Interacts with
CC       BOK; regulates ITPR3 expression (PubMed:23884412). Interacts with
CC       BCL2L10 (By similarity). Interacts with CHGA and CHGB (By similarity).
CC       {ECO:0000250|UniProtKB:P70227, ECO:0000250|UniProtKB:Q14573,
CC       ECO:0000250|UniProtKB:Q8WN95, ECO:0000269|PubMed:11149946,
CC       ECO:0000269|PubMed:11163362, ECO:0000269|PubMed:12032348,
CC       ECO:0000269|PubMed:23884412}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:8388391}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000250|UniProtKB:Q8WN95}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Also localizes at mitochondria-associated membranes
CC       (MAMs). {ECO:0000250|UniProtKB:P70227}.
CC   -!- DOMAIN: Composed of a large N-terminal cytoplasmic domain (CD) followed
CC       by a juxtamembrane domain (JD) and a transmembrane domain (TMD).
CC       {ECO:0000250|UniProtKB:Q14573}.
CC   -!- PTM: Phosphorylated by AKT1 on serine and/or threonine residues (By
CC       similarity). {ECO:0000250|UniProtKB:P70227}.
CC   -!- SIMILARITY: Belongs to the InsP3 receptor family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L06096; AAA41446.1; -; mRNA.
DR   PIR; A46719; A46719.
DR   RefSeq; NP_037270.1; NM_013138.1.
DR   AlphaFoldDB; Q63269; -.
DR   SMR; Q63269; -.
DR   BioGRID; 247708; 3.
DR   IntAct; Q63269; 3.
DR   MINT; Q63269; -.
DR   STRING; 10116.ENSRNOP00000075066; -.
DR   ChEMBL; CHEMBL2846; -.
DR   TCDB; 1.A.3.2.5; the ryanodine-inositol 1,4,5-triphosphate receptor ca(2+) channel (rir-cac) family.
DR   CarbonylDB; Q63269; -.
DR   GlyGen; Q63269; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q63269; -.
DR   PhosphoSitePlus; Q63269; -.
DR   jPOST; Q63269; -.
DR   PaxDb; 10116-ENSRNOP00000011516; -.
DR   GeneID; 25679; -.
DR   KEGG; rno:25679; -.
DR   UCSC; RGD:2934; rat.
DR   AGR; RGD:2934; -.
DR   CTD; 3710; -.
DR   RGD; 2934; Itpr3.
DR   eggNOG; KOG3533; Eukaryota.
DR   InParanoid; Q63269; -.
DR   OrthoDB; 5480299at2759; -.
DR   PhylomeDB; Q63269; -.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   Reactome; R-RNO-5578775; Ion homeostasis.
DR   Reactome; R-RNO-9717207; Sensory perception of sweet, bitter, and umami (glutamate) taste.
DR   Reactome; R-RNO-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   PRO; PR:Q63269; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0045177; C:apical part of cell; IDA:BHF-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0005903; C:brush border; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0098554; C:cytoplasmic side of endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0005640; C:nuclear outer membrane; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0030667; C:secretory granule membrane; IBA:GO_Central.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0015085; F:calcium ion transmembrane transporter activity; TAS:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0043533; F:inositol 1,3,4,5 tetrakisphosphate binding; IDA:RGD.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IDA:RGD.
DR   GO; GO:0005220; F:inositol 1,4,5-trisphosphate-gated calcium channel activity; IDA:RGD.
DR   GO; GO:0000822; F:inositol hexakisphosphate binding; IDA:RGD.
DR   GO; GO:0015278; F:intracellularly gated calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; IDA:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0007613; P:memory; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IBA:GO_Central.
DR   GO; GO:0051592; P:response to calcium ion; ISO:RGD.
DR   GO; GO:0050913; P:sensory perception of bitter taste; ISO:RGD.
DR   GO; GO:0050916; P:sensory perception of sweet taste; ISO:RGD.
DR   GO; GO:0050917; P:sensory perception of umami taste; ISO:RGD.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 2.80.10.50; -; 2.
DR   Gene3D; 1.25.10.30; IP3 receptor type 1 binding core, RIH domain; 1.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR000493; InsP3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR015925; Ryanodine_IP3_receptor.
DR   InterPro; IPR035910; RyR/IP3R_RIH_dom_sf.
DR   PANTHER; PTHR45816:SF1; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; 1.
DR   PANTHER; PTHR45816; MIR DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   PRINTS; PR00779; INSP3RECEPTR.
DR   SMART; SM00472; MIR; 4.
DR   SUPFAM; SSF100909; IP3 receptor type 1 binding core, domain 2; 2.
DR   SUPFAM; SSF82109; MIR domain; 2.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   ATP-binding; Calcium; Calcium channel; Calcium transport;
KW   Cytoplasmic vesicle; Disulfide bond; Endoplasmic reticulum; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport; Zinc.
FT   CHAIN           1..2670
FT                   /note="Inositol 1,4,5-trisphosphate-gated calcium channel
FT                   ITPR3"
FT                   /id="PRO_0000153930"
FT   TOPO_DOM        1..2201
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2202..2222
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2223..2233
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2234..2254
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2255..2263
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2264..2284
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2285..2324
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2325..2345
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2346..2367
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2368..2388
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2389..2495
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2496..2516
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2517..2670
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          113..173
FT                   /note="MIR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          174..224
FT                   /note="MIR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          232..288
FT                   /note="MIR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          295..372
FT                   /note="MIR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          378..434
FT                   /note="MIR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   REGION          321..344
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1132..1164
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1807..1849
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1132..1161
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1827..1841
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         266
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         268
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         269
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         270
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         503
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         507
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         510
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         567
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         568
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         569
FT                   /ligand="1D-myo-inositol 1,4,5-trisphosphate"
FT                   /ligand_id="ChEBI:CHEBI:203600"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         743
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1122
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1125
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /ligand_note="low affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1881
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1945
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         1995
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2148
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2151
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2537
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2537
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2538
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2540
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2557
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2559
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2562
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2562
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2563
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2564
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   BINDING         2580
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /ligand_note="high affinity"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   MOD_RES         916
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   MOD_RES         934
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1813
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   MOD_RES         1832
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   MOD_RES         1834
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   MOD_RES         2608
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
FT   MOD_RES         2669
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   DISULFID        2454..2460
FT                   /evidence="ECO:0000250|UniProtKB:Q14573"
SQ   SEQUENCE   2670 AA;  304286 MW;  13C787E4C2886E45 CRC64;
     MNEMSSFLHI GDIVSLYAEG SVNGFISTLG LVDDRCVVEP AAGDLDNPPK KFRDCLFKVC
     PMNRYSAQKQ YWKAKQTKQD KEKIADVVLL QKLQHAAQME QKQNDTENKK VHGDVVKYGS
     VIQLLHMKSN KYLTVNKRLP ALLEKNAMRV TLDATGNEGS WLFIQPFWKL RSNGDNVVVG
     DKVILNPVNA GQPLHASNYE LSDNVGCKEV NSVNCNTSWK INLFMQFRDH LEEVLKGGDV
     VRLFHAEQEK FLTCDEYRGK LQVFLRTTLR QSATSATSSN ALWEVEVVHH DPCRGGAGHW
     NGLYRFKHLA TGNYLAAEEN PSYKGDVSDP KAAGPGAQSR TGRRNAGEKI KYRLVAVPHG
     NDIASLFELD PTTLQKTDSF VPRNSYVRLR HLCTNTWIQS TNAPIDVEEE RPIRLMLGTC
     PTKEDKEAFA IVSVPVSEIR DLDFANDASS MLASAVEKLN EGFISQNDRR FVIQLLEDLV
     FFVSDVPNNG QNVLDIMVTK PNRERQKLMR DENILKQIFG ILKAPFRDKG GEGPLVRLEE
     LSDQKNAPYQ YMFRLCYRVL RHSQEDYRKN QEHIAKQFGM MQSQIGYDIL AEDTITALLH
     NNRKLLEKHI TKTEVETFVS LVRKNREPRF LDYLSDLCVS NRIAIPVTQE LICKCVLDPK
     NSDILIQTEL RPVKEMAQSH EYLSIEYSEE EVWLTWTDRN NEHHEKSVRQ LAQEARAGNA
     HDENVLSYYR YQLKLFARMC LDRQYLAIDE ISKQLGVELL FLCMADEMLP FDLRASFCHL
     MLHVHVDRDP QELVTPVKFA RLWTEIPTAI TIKDYDSNLN ASRDDKKNKF ASTMEFVEDY
     LNNVVGEAVP FANDEKNILT FEVVSLAHNL IYFGFYSFSE LLRLTRTLLG IIDCIQAPAA
     VLQAYEEPGG KNVRRSIQGV GHMMSTMVLS RKQSVFGASS LPTGVGVPEQ LDRSKFEDNE
     HTVVMETKLK ILEILQFILN VRLDYRISYL LSVFKKEFVE VFPMQDSGAD GTAPAFDSST
     ANMNLDRIGE QAEAMFGVGK TSSMLEVDDE GGRMFLRVLL HLTMHDYPPL VSGALQLLFK
     HFSQRQEAMH TFKQVQLLIS AQDVENYKVI KSELDRLRTM VEKSELWVDK KGSVKGEEGE
     AGASKDKKER PSDEEGFLQP HGEKSSENYQ IVKGILERLN KMCGVGEQMR KKQQRLLKNM
     DAHKVMLDLL QIPYDKNDNK MMEILRYTHQ FLQKFCAGNP GNQALLHKHL QLFLTPGLLE
     AETMQHIFLN NYQLCSEISE PVLQHFVHCW PTHGRHVQYL DFLHTVIKAE GKYVKKCQDM
     IMTELTNAGD DVVVFYNDKA SLAHLLDMMK AARDGVEDHS PLMYHISLVD LLAACAEGKN
     VYTEIKCTSL LPLEDVVSVV THEDCITEVK MAYVNFVNHC YVDTEVEMKE IYTSNHIWTL
     FENFTLDMAL VCNKREKRLS DPTLEKYVLT VVLDTISAFF SSPFSENSTS LQTHQTIVVQ
     LLQSTTRLLE CPWLQQQHKG SVEACVRTLA MVAKSRAILL PMDLDAHMSA LLSSGGSCSA
     AAQRSAANYK TATRTFPRVI PTANQWDYKN IIEKLQDIIT ALEERLKPLV QAELSVLVDM
     LHWPELLFLE GSEAYQRCES GGFLSKLIRH TKGLMESEEK LCVKVLRTLQ QMLQKKSKYG
     DRGNQLRKML LQNYLQNRKS GPRGELTDPT GSGVDQDWSA IAATQCRLDK EGATKLVCDL
     ITSTKNEKIF QESIGLAIRL LDGGNTEIQK SFYNLMTSDK KSERFFKVLH DRMKRAQQET
     KSTVAVNMSD LGSQPREDRE PADPTTKGRV SSFSMPSSSR YSLGPGLHRG HDVSERAQNN
     EMGTSVLIMR PILRFLQLLC ENHNRDLQNF LRCQNNKTNY NLVCETLQFL DIMCGSTTGG
     LGLLGLYINE DNVGLVIQTL ETLTEYCQGP CHENQTCIVT HESNGIDIIT ALILNDISPL
     CKYRMDLVLQ LKDNASKLLL ALMESRHDSE NAERILISLR PQELVDVIKK AYLQEEEREN
     SEVSPREVGH NIYILALQLS RHNKQLQHLL KPVKRIQEEE AEGISSMLSL NNKQLSQMLK
     SSAPAQEEEE DPLAYYENHT SQIEIVRQDR SMEQIVFPVP AICQFLTEET KHRLFTTTEQ
     DEQGSKVSDF FDQSSFLHNE MEWQRRLRSM PLIYWFSRRM TLWGSISFNL AVFINIIIAF
     FYPYVEGAST GVLGSPLISL LFWILICFSI AALFTKHYSV RPLIVALVLR SIYYLGIGPT
     LNILGALNLT NKIVFVVSFV GNRGTFIRGY KAMVMDMEFL YHVGYILTSV LGLFAHELFY
     SILLFDLIYR EETLFNVIKS VTRNGRSILL TALLALILVY LFSIVGFLFL KDDFILEVDR
     LPGNHSRAST LGMPHGAATF MGTCSGDKMD CVSEVSVPEI LEEDEELDST ERACDTLLMC
     IVTVMNHGLR NGGGVGDILR KPSKDESLFP ARVVYDLLFF FIVIIIVLNL IFGVIIDTFA
     DLRSEKQKKE EILKTTCFIC GLERDKFDNK TVSFEEHIKL EHNMWNYLYF IVLVRVKNKT
     DYTGPESYVA QMIKNKNLDW FPRMRAMSLV SGEGEGEQNE IRILQEKLGS TMKLVSHLTA
     QLNELKEQMT EQRKRRQRLG FVDVQNCMSR
//
